Depressed expression of angiogenic growth factors in the subacute phase of myocardial ischemia: A mechanism behind the remodeling plateau?

Coronary Artery Disease

Volumn 21, Issue 2, 2010, Pages 65-71

  Siddiqui, Anwar Jewel ^a   Fischer, Helene ^a   Widegren, Ulrika ^a   Grinnemo, Karl Henrik ^b   Hao, Xiaojin ^a   Månsson Broberg, Agneta ^a   Sylvén, Christer ^a   Gustafsson, Thomas ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myocardial infarction; Angiopoietin; Arteriogenesis; Gene transfer; Receptor; Vascular endothelial growth factor

Indexed keywords

ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; CITRATE SYNTHASE; PROTEIN KINASE B; VASCULOTROPIN 165; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; GENE EXPRESSION; GENE TRANSFER; HEART FUNCTION; HEART MUSCLE ISCHEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANGIOGENIC PROTEINS; ANGIOPOIETIN-1; ANGIOPOIETIN-2; ANIMALS; CITRATE (SI)-SYNTHASE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE THERAPY; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; VENTRICULAR REMODELING;

EID: 77249133715     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCA.0b013e3283349cbb     Document Type: Article

References (27)

1. Werner GS, Surber R, Kuethe F, Emig U, Schwarz G, Bahrmann P, et al. Collaterals and the recovery of left ventricular function after recanalization of a chronic total coronary occlusion. Am Heart J 2005; 149:129-137.
2. Heil M, SchaperW. Pathophysiology of collateral development. Coron Artery Dis 2004; 15:373-378.
3. Pohl T, Seiler C, Billinger M, Herren E, Wustmann K, Mehta H, et al. Frequency distribution of collateral flow and factors influencing collateral channel development. Functional collateral channel measurement in 450 patients with coronary artery disease. J AmColl Cardiol 2001; 38:1872-1878.
4. Fedele FA, Gewirtz H, Capone RJ, Sharaf B, Most AS. Metabolic response to prolonged reduction of myocardial blood flow distal to a severe coronary artery stenosis. Circulation 1988; 78:729-735. (Pubitemid 18211295)
5. Schulz R, Guth BD, Pieper K, Martin C, Heusch G. Recruitment of an inotropic reserve in moderately ischemic myocardium at the expense of metabolic recovery. A model of short-term hibernation. Circ Res 1992; 70:1282-1295.
6. Rahimtoola SH. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation 1985; 72:V123-V135.
7. Offstad J, Kirkeboen KA, Lande K, Ilebekk A. Cardiac adaptation to one hour of mild regional low flow ischaemia in the pig. Cardiovasc Res 1993; 27:2248-2253.
8. Redwood SR, Ferrari R, Marber MS. Myocardial hibernation and stunning: from physiological principles to clinical practice. Heart 1998; 80:218-222.
9. Fluck M, Hoppeler H. Molecular basis of skeletal muscle plasticity - from gene to form and function. Rev Physiol Biochem Pharmacol 2003; 146:159-216.
10. Ananthakrishnan R, Moe GW, Goldenthal MJ, Marin-Garcia J. Akt signaling pathway in pacing-induced heart failure. Mol Cell Biochem 2005; 268:103-110.
11. Cook SA, Matsui T, Li L, Rosenzweig A. Transcriptional effects of chronic Akt activation in the heart. J Biol Chem 2002; 277:22528-22533.
12. Ackah E, Yu J, Zoellner S, Iwakiri Y, Skurk C, Shibata R, et al. Akt1/protein kinase Balpha is critical for ischemic and VEGF-mediated angiogenesis. J Clin Invest 2005; 115:2119-2127.
13. Skurk C, Izumiya Y, Maatz H, Razeghi P, Shiojima I, Sandri M, et al. The FOXO3a transcription factor regulates cardiac myocyte size downstream of AKT signaling. J Biol Chem 2005; 280:20814-20823.
14. DeBosch B, Treskov I, Lupu TS,Weinheimer C, Kovacs A, Courtois M, et al. Akt1 is required for physiological cardiac growth. Circulation 2006; 113:2097-2104.
15. Siddiqui AJ, Blomberg P, Wardell E, Hellgren I, Eskandarpour M, Islam KB, et al. Combination of angiopoietin-1 and vascular endothelial growth factor gene therapy enhances arteriogenesis in the ischemic myocardium. Biochem Biophys Res Commun 2003; 310:1002-1009.
16. Hao X, Mansson-Broberg A, Grinnemo KH, Siddiqui AJ, Dellgren G, Brodin LA, et al. Myocardial angiogenesis after plasmid or adenoviral VEGF-A(165) gene transfer in rat myocardial infarction model. Cardiovasc Res 2007; 73:481-487.
17. Siddiqui AJ, Gustafsson T, Fischer H,Widegren U, Hao X, Mansson-Broberg A, et al. Simvastatin enhances myocardial angiogenesis induced by vascular endothelial growth factor gene transfer. J Mol Cell Cardiol 2004; 37:1235-1244.
18. Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25:169-193.
19. Holash J, Maisonpierre PC, Compton D, Boland P, Alexander CR, Zagzag D, et al. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. Science 1999; 284:1994-1998.
20. Banai S, Shweiki D, Pinson A, Chandra M, Lazarovici G, Keshet E. Upregulation of vascular endothelial growth factor expression induced by myocardial ischaemia: implications for coronary angiogenesis. Cardiovasc Res 1994; 28:1176-1179.
21. Matsunaga T,Warltier DC, Tessmer J,Weihrauch D, Simons M, Chilian WM. Expression of VEGF and angiopoietins-1 and -2 during ischemia-induced coronary angiogenesis. Am J Physiol Heart Circ Physiol 2003; 285:H352-H358.
22. Pugh CW, Ratcliffe PJ. Regulation of angiogenesis by hypoxia: role of the HIF system. Nat Med 2003; 9:677-684.
23. Ruck A, Gustafsson T, Norrbom J, Nowak J, Kallner G, Soderberg M, et al. ANP and BNP but not VEGF are regionally overexpressed in ischemic human myocardium. Biochem Biophys Res Commun 2004; 322:287-291.
24. Wang Y, Gabrielsen A, Lawler PR, Paulsson-Berne G, Steinbruchel DA, Hansson GK, et al. Myocardial gene expression of angiogenic factors in human chronic ischemic myocardium: influence of acute ischemia/ cardioplegia and reperfusion. Microcirculation 2006; 13:187-197.
25. Giordano FJ, Gerber HP, Williams SP, VanBruggen N, Bunting S, Ruiz-Lozano P, et al. A cardiac myocyte vascular endothelial growth factor paracrine pathway is required to maintain cardiac function. Proc Natl Acad Sci U S A 2001; 98:5780-5785.
26. Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi A, et al. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Mol Ther 2003; 7:450-459.
27. Siddiqui AJ, Mansson-Broberg A, Gustafsson T, Grinnemo KH, Dellgren G, Hao X, et al. Antagonism of the renin-angiotensin system can counteract cardiac angiogenic vascular endothelial growth factor gene therapy and myocardial angiogenesis in the normal heart. Am J Hypertens 2005; 18:1347-1352.